Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329)

Currency in CNY
38.29
-0.01(-0.03%)
Closed·
Earnings results expected in 13 days
High dividend Yield
600329 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
37.8638.43
52 wk Range
34.7050.97
Key Statistics
Bid/Ask
38.28 / 38.29
Prev. Close
38.3
Open
37.9
Day's Range
37.86-38.43
52 wk Range
34.7-50.97
Volume
3.26M
Average Volume (3m)
4.45M
1-Year Change
-1.2126%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
600329 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
0.00
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 0.00

Earnings

Latest Release
Apr 29, 2026
EPS / Forecast
0.55 / --
Revenue / Forecast
1.52B / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 2.83%
Dividend Yield
12.51%
Industry Median 1.79%
Annualized payout
4.79
Paid annually
5-Years Growth
+74.04%
Growth Streak

600329 Income Statement

Compare 600329 to Peers and Sector

Metrics to compare
600329
Peers
Sector
Relationship
P/E Ratio
11.7x19.7x−0.3x
PEG Ratio
−6.151.230.00
Price/Book
3.4x2.4x2.6x
Price / LTM Sales
5.1x3.0x3.0x
Upside (Analyst Target)
-26.4%56.3%
Fair Value Upside
Unlock18.1%9.2%Unlock

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited engages in the research, development, processing, manufacturing, and sale of traditional Chinese medicine in China. It provides pharmaceutical products for cardiovascular and cerebrovascular, skin wound repair, health preservation, respiratory, digestion, rheumatism and osteodynia, urological, gynecological and pediatric, ophthalmological, tumor, chronic, and other diseases, as well as tonic drugs. The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. The company was founded in 1915 and is based in Tianjin, the People’s Republic of China.

Employees
3890
Market
China

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
12.93M1.68%495.06M
Other Institutional Investors
395.66M51.38%15.15B
Public Companies & Retail Investors
361.50M46.94%13.84B
Total
770.09M100.00%29.49B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Jinhushen Biomedical Technology Co., Ltd.43.01%331,202,72812,681,752
Futu Singapore Pte. Ltd.3.50%26,938,7151,031,483

People Also Watch

43.44
002422
+1.52%
80.62
000408
+1.03%
81.00
000661
+0.63%
29.11
000963
-1.29%

FAQ

What Is the Tianjin Zhongxin Pharm (600329) Stock Price Today?

The Tianjin Zhongxin Pharm stock price today is 38.29 CNY.

What Stock Exchange Does Tianjin Zhongxin Pharm Trade On?

Tianjin Zhongxin Pharm is listed and trades on the Shanghai Stock Exchange.

What Is the Stock Symbol for Tianjin Zhongxin Pharm?

The stock symbol for Tianjin Zhongxin Pharm is "600329."

Does Tianjin Zhongxin Pharm Pay Dividends? What’s The Current Dividend Yield?

The Tianjin Zhongxin Pharm dividend yield is 12.51%.

What Is the Tianjin Zhongxin Pharm Market Cap?

As of today, Tianjin Zhongxin Pharm market cap is 25.60B CNY.

What Is Tianjin Zhongxin Pharm's Earnings Per Share (TTM)?

The Tianjin Zhongxin Pharm EPS (TTM) is 2.83.

When Is the Next Tianjin Zhongxin Pharm Earnings Date?

Tianjin Zhongxin Pharm will release its next earnings report on Aug 15, 2026.

From a Technical Analysis Perspective, Is 600329 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Tianjin Zhongxin Pharm Stock Split?

Tianjin Zhongxin Pharm has split 2 times.

How Many Employees Does Tianjin Zhongxin Pharm Have?

Tianjin Zhongxin Pharm has 3890 employees.

What is the current trading status of Tianjin Zhongxin Pharm (600329)?

As of Aug 02, 2026, Tianjin Zhongxin Pharm (600329) is trading at a price of 38.29 CNY, with a previous close of 38.30 CNY. The stock has fluctuated within a day range of 37.86 CNY to 38.43 CNY, while its 52-week range spans from 34.70 CNY to 50.97 CNY.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.